Talquetamab-Induced Grover's Disease
Journal of Drugs in Dermatology · 2023-08-01 · 22 (8) · 828-829
DOI: 10.36849/jdd.7170 ↗At a glance
Journal article in Journal of Drugs in Dermatology, published online on 2023-07-01. Written by Mindy Kresch and 4 co-authors. Major MEDLINE topics: Acantholysis, Ichthyosis. Cited 10 times so far (Crossref).
Abstract (original language)
Kresch M, Guénin S, Mubasher A, et al. Talquetamab-induced Grover’s disease. J Drugs Dermatol. 2023;22(8):828-829. doi:10.36849/JDD.7170.
Subjects
MeSH terms (MEDLINE)
Cite
APA
Kresch, M., Guenin, S., Mubasher, A., Elbogen, E., & Lebwohl, M. (2023). Talquetamab-Induced Grover's Disease. Journal of Drugs in Dermatology, 22(8), 828-829. https://doi.org/10.36849/jdd.7170
Vancouver
Kresch M, Guenin S, Mubasher A, Elbogen E, Lebwohl M. Talquetamab-Induced Grover's Disease. Journal of Drugs in Dermatology. 2023;22(8):828-829. doi:10.36849/jdd.7170
BibTeX
@article{Kresch2023,
author = {Kresch, Mindy and Guenin, Sophie and Mubasher, Adnan and Elbogen, Emily and Lebwohl, Mark},
title = {Talquetamab-Induced Grover's Disease},
journal = {Journal of Drugs in Dermatology},
year = {2023},
volume = {22},
number = {8},
pages = {828--829},
doi = {10.36849/jdd.7170}
}
EUVIMED